DICE Therapeutics (NASDAQ:DICE) Stock Rating Lowered by Guggenheim

Guggenheim cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a neutral rating in a report published on Wednesday morning, The Fly reports. DICE has been the topic of several other reports. Cowen assumed coverage on shares of DICE Therapeutics in a research note on Wednesday, March 1st. They set […]

Related Keywords

Richardh Scheller , ,Therapeutics Company Profile ,Blackrock Inc ,Pricet Rowe Associates Inc ,Nasdaq ,Therapeutics Inc ,Northpond Ventures Gp Llc ,Cantor Fitzgerald ,Avoro Capital Advisors ,Wells Fargo Company ,Get Rating ,Director Richard ,Capital Advisors ,Dice Therapeutics ,Nasdaq Dice ,Dice ,Medical ,Downgrade ,Guggenheim ,